All Sessions by Todd Kilbaugh
5:15 pm
-
7:00 pm
POB.130 - Clinical Trial of Inhaled Nitric Oxide for Treatment of Microvascular Dysfunction in Acute Traumatic Brain Injury: Preliminary Report
5:15 pm
-
7:00 pm
POB.158 - Fc-Engineered Monoclonal Antibodies Targeting neoGFAP™ as a Disease-Modifying Immunotherapy for Traumatic Brain Injury
4:30 pm
-
6:30 pm